nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: A prospective, two-year, single center, pilot study
|
Papamichael, Konstantinos |
|
2012 |
6 |
9 |
p. 924-931 8 p. |
artikel |
2 |
Alopecia Areata: A possible extraintestinal manifestation of Crohn's disease
|
Ganzetti, Giulia |
|
2012 |
6 |
9 |
p. 962-963 2 p. |
artikel |
3 |
An unusual presentation of T-lymphoma in a Crohn's disease patient treated with combo therapy: We are willing to take a risk of serious adverse events for a doubtful benefit?
|
Sinagra, Emanuele |
|
2012 |
6 |
9 |
p. 954-955 2 p. |
artikel |
4 |
Circulating MicroRNA in inflammatory bowel disease
|
Paraskevi, Archanioti |
|
2012 |
6 |
9 |
p. 900-904 5 p. |
artikel |
5 |
Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity
|
Saurer, Leslie |
|
2012 |
6 |
9 |
p. 913-923 11 p. |
artikel |
6 |
Enteroendocrine cells in terminal ileal Crohn's disease
|
Moran, Gordon W. |
|
2012 |
6 |
9 |
p. 871-880 10 p. |
artikel |
7 |
Has primary sclerosing cholangitis associated with Crohn's disease a better outcome?
|
Ngu, Jing H. |
|
2012 |
6 |
9 |
p. 956- 1 p. |
artikel |
8 |
Histopathological characterization of cholecystectomy specimens in patients with inflammatory bowel disease
|
Lin, Jingmei |
|
2012 |
6 |
9 |
p. 895-899 5 p. |
artikel |
9 |
Intolerance of folic acid in a patient receiving methotrexate for Crohn's disease
|
Katsanos, Konstantinos H. |
|
2012 |
6 |
9 |
p. 960- 1 p. |
artikel |
10 |
Is patient reported outcome (PRO) affected by different follow-up regimens in inflammatory bowel disease (IBD)? A one year prospective, longitudinal comparison of nurse-led versus conventional follow-up
|
Jelsness-Jørgensen, Lars-Petter |
|
2012 |
6 |
9 |
p. 887-894 8 p. |
artikel |
11 |
Issue Contents list
|
|
|
2012 |
6 |
9 |
p. v-vi nvt p. |
artikel |
12 |
Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn's disease: report of two cases, including cerebral tuberculomas and miliary tuberculosis
|
Tissot, Claire |
|
2012 |
6 |
9 |
p. 946-949 4 p. |
artikel |
13 |
Microscopic colitis: Current status, present and future challenges
|
Münch, A. |
|
2012 |
6 |
9 |
p. 932-945 14 p. |
artikel |
14 |
Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol
|
Smith, Melissa A. |
|
2012 |
6 |
9 |
p. 905-912 8 p. |
artikel |
15 |
Probable diffuse retinopathy caused by adalimumab in a patient with Crohn's disease
|
Marticorena-Álvarez, Paula |
|
2012 |
6 |
9 |
p. 950-953 4 p. |
artikel |
16 |
Recurrent orbital myositis as an extra-intestinal manifestation of Crohn's disease
|
Pimentel, Rita |
|
2012 |
6 |
9 |
p. 958-959 2 p. |
artikel |
17 |
Reply to Dr. Ngu et al.'s letter
|
Halliday, John |
|
2012 |
6 |
9 |
p. 957- 1 p. |
artikel |
18 |
Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment
|
Casellas, Francesc |
|
2012 |
6 |
9 |
p. 881-886 6 p. |
artikel |
19 |
S100A12 in EDTA plasma – A cautionary tale
|
Meijer, B. |
|
2012 |
6 |
9 |
p. 961- 1 p. |
artikel |